Thalerommata Ausserer, 1875 is a theraphosid genus with very small species that resemble Trichopelma, although they lack the dot pattern on the abdomen. They are also distinguished from all other Theraphosidae by the presence of flattened, iridescent setae covering the abdomen, and sometimes, the legs too. Its current distribution includes the following countries: Argentina, Bahamas, Colombia, Cuba, Jamaica and Venezuela.
View Article and Find Full Text PDFBackground And Purpose: Despite that incorporating antiangiogenic in combination with immune-checkpoint inhibitors as the standard first-line treatment for advanced clear cell renal cell cancer (ccRCC) yields promising outcomes, these regimens often lead to significant toxicity. However, a subgroup of patients has shown responsiveness to VEGFR tyrosine-kinase inhibitors (TKIs) in monotherapy, leading to the question of whether employing combination therapies can significantly enhance overall survival in all patients over monotherapy. Thus, we aim to identify gene expression signatures that can predict TKI response within subpopulations that might benefit from single-agent therapies, to minimize unnecessary exposure to combination therapies and their associated toxicities, as well as to discover new potential therapeutic targets to improve ccRCC treatment.
View Article and Find Full Text PDFRenal ischaemia and reperfusion (I/R) is caused by a sudden temporary impairment of the blood flow. I/R is a prevalent cause of acute kidney injury. As nitric oxide generated by inducible nitric oxide synthase (iNOS) has detrimental effects during I/R, the pharmacological blockade of iNOS has been proposed as a potential strategy to prevent I/R injury.
View Article and Find Full Text PDF